Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$6.66 - $10.92 $562,104 - $921,648
-84,400 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$4.59 - $18.74 $34,264 - $139,894
-7,465 Reduced 8.13%
84,400 $788,000
Q4 2020

Feb 02, 2021

SELL
$3.93 - $5.5 $6,681 - $9,350
-1,700 Reduced 1.82%
91,865 $441,000
Q3 2020

Nov 05, 2020

BUY
$4.01 - $5.56 $44,370 - $61,521
11,065 Added 13.41%
93,565 $375,000
Q2 2020

Aug 12, 2020

BUY
$3.0 - $5.52 $162,900 - $299,736
54,300 Added 192.55%
82,500 $379,000
Q1 2020

May 12, 2020

SELL
$2.54 - $4.75 $18,051 - $33,758
-7,107 Reduced 20.13%
28,200 $92,000
Q4 2019

Jan 27, 2020

BUY
$2.83 - $4.61 $99,918 - $162,765
35,307 New
35,307 $152,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $510M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.